AN2 Therapeutics's top three insider shareholders as of August 29, 2026 are Braden Michael Leonard (TenPercentOwner, 3.02Mn shares), Kabeer Aziz (Director, 2.47Mn shares), Kabeer Aziz (Director, 2.47Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Braden Michael Leonard | TenPercentOwner | 0 | 3,017,432 | 3,017,432 | 40.7% | 16 Jun, 2025 |
| 2 | Global Health Technology Fund, L.P. Adjuvant | TenPercentOwner | 1,995,958 | 377,542 | 2,373,500 | 32.0% | 18 Jan, 2024 |
| 3 | Robin Shane Readnour | Director | 0 | 633,867 | 633,867 | 8.6% | 19 Aug, 2026 |
| 4 | Eric Easom | Chief Executive Officer | 368,630 | 0 | 368,630 | 5.0% | 23 Feb, 2026 |
| 5 | Joshua M Eizen | Chief Legal Officer | 206,554 | 0 | 206,554 | 2.8% | 10 Jul, 2026 |
| 6 | Joseph S Zakrzewski | Director | 145,538 | 0 | 145,538 | 2.0% | 11 Apr, 2025 |
| 7 | Sanjay Chanda | Chief Development Officer | 118,823 | 0 | 118,823 | 1.6% | 23 Feb, 2026 |
| 8 | Lucy Day | Chief Financial Officer | 118,363 | 0 | 118,363 | 1.6% | 23 Feb, 2026 |
| 9 | Paul Eckburg | Chief Medical Officer | 102,832 | 0 | 102,832 | 1.4% | 29 Mar, 2024 |
| 10 | Gilbert Lynn Marks | Director | 81,873 | 0 | 81,873 | 1.1% | 10 Jul, 2026 |
| 11 | Sarah Joanne Williams | Principal Accounting Officer | 66,583 | 0 | 66,583 | 0.9% | 02 Jun, 2026 |
| 12 | Kabeer Aziz | Director | 59,106 | 0 | 59,106 | 0.8% | 10 Jul, 2026 |
| 13 | Stephen David Prior | Chief Strategy Officer | 59,086 | 0 | 59,086 | 0.8% | 07 Jan, 2026 |
| 14 | Kevin Michael Krause | Chief Strategy Officer | 31,914 | 0 | 31,914 | 0.4% | 29 Mar, 2024 |
| 15 | Patricia A. Martin | Director | 18,863 | 0 | 18,863 | 0.3% | 10 Jul, 2026 |
| 16 | Margaret M Fitzpatrick | Director | 8,610 | 0 | 8,610 | 0.1% | 29 May, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 17 Aug, 2026 | Robin Shane Readnour | Director | Disposed S | 16,696 | $6.01 | $100.31K | 565,592 | Indirect |
| 17 Aug, 2026 | Robin Shane Readnour | Director | Disposed S | 18,706 | $6.01 | $112.39K | 633,867 | Indirect |
| 14 Aug, 2026 | Joseph S Zakrzewski | Director | Disposed G | 405,880 | $0.00 | $0 | 0 | Indirect |
| 10 Jul, 2026 | Gilbert Lynn Marks | Director | Acquired A | 2,789 | $0.00 | $0 | 81,873 | Direct |
| 10 Jul, 2026 | Patricia A. Martin | Director | Acquired A | 766 | $0.00 | $0 | 18,863 | Direct |
| 10 Jul, 2026 | Kabeer Aziz | Director | Acquired A | 2,852 | $0.00 | $0 | 59,106 | Direct |
| 08 Jul, 2026 | Joshua M Eizen | Officer | Disposed S | 5,945 | $4.17 | $24.80K | 206,554 | Direct |
| 29 May, 2026 | Sarah Joanne Williams | Principal Accounting Officer | Disposed S | 265 | $4.43 | $1.17K | 66,583 | Direct |
| 10 Apr, 2026 | Kabeer Aziz | Director | Acquired A | 3,775 | $0.00 | $0 | 56,254 | Direct |
| 10 Apr, 2026 | Kabeer Aziz | Director | Acquired A | 3,775 | $0.00 | $0 | 56,254 | Direct |
| 10 Apr, 2026 | Gilbert Lynn Marks | Director | Acquired A | 3,775 | $0.00 | $0 | 79,084 | Direct |
| 10 Apr, 2026 | Kabeer Aziz | Director | Acquired A | 3,775 | $0.00 | $0 | 56,254 | Direct |
| 10 Apr, 2026 | Kabeer Aziz | Director | Acquired A | 3,775 | $0.00 | $0 | 56,254 | Direct |
| 10 Apr, 2026 | Patricia A. Martin | Director | Acquired A | 1,192 | $0.00 | $0 | 18,097 | Direct |
| 19 Mar, 2026 | Joseph S Zakrzewski | Director | Acquired A | 99,999 | — | — | 99,999 | Direct |
| 19 Mar, 2026 | Melvin K Spigelman | Director | Acquired A | 16,941 | — | — | 16,941 | Direct |
| 19 Mar, 2026 | Eric Easom | Chief Executive Officer | Acquired A | 249,999 | — | — | 249,999 | Direct |
| 19 Mar, 2026 | Stephanie Wong | Director | Acquired A | 24,999 | — | — | 24,999 | Direct |
| 19 Mar, 2026 | Robin Shane Readnour | Director | Acquired A | 20,724 | — | — | 20,724 | Direct |
| 19 Mar, 2026 | Stephanie Wong | Director | Acquired A | 24,999 | — | — | 24,999 | Direct |